Medical Research News

RSS

Recovered COVID-19 patients show signs of long-term immunity

A study conducted by researchers in the United States has found that most patients who recovered from coronavirus disease 2019 (COVID-19) showed signs of long-lasting immunity against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Apr 2021

Higher ratio of green spaces associated with reduced disparity in coronavirus infection rates

A higher ratio of green spaces at the county level is associated with a lower racial disparity in coronavirus infection rates, according to a new study.

28 Apr 2021

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

With COVID-19 vaccines more readily available than ever, there remains vaccine hesitancy in diverse communities across metropolitan Houston and beyond.

28 Apr 2021

Brazilian coronavirus variant could pose a bigger threat than previously assumed

A new study with the University of Copenhagen represented indicates that the coronavirus variant called P.1, which originated in Brazil, could pose a bigger threat than previously assumed.

28 Apr 2021

Purified exosomal product accelerates wound healing in preclinical models

Difficult-to-treat, chronic wounds in preclinical models healed with normal scar-free skin after treatment with an acellular product discovered at Mayo Clinic.

28 Apr 2021

Young people of color with a higher income more likely to participate in cancer clinical trials

People of color, those with a higher income and younger individuals are more likely to participate in clinical trials during their cancer treatment according to a new study from the University of Missouri School of Medicine.

28 Apr 2021

Mutation in a cancer-causing gene could exacerbate cerebral cavernous malformations in the brain

Researchers have discovered an explanation for why cerebral cavernous malformations (CCMs)--clusters of dilated blood vessels in the brain--can suddenly grow to cause seizures or stroke.

28 Apr 2021

Involuntary job changes are frequent among breast cancer patients

Breast cancer diagnosis: Around 88 percent of patients survive the dangerous disease in the first five years. Work is important for getting back to normality.

28 Apr 2021

Study explores link between text anxiety and poor sleep

College students across the country struggle with a vicious cycle: Test anxiety triggers poor sleep, which in turn reduces performance on the tests that caused the anxiety in the first place.

28 Apr 2021

Topical therapy can help safely reduce side effect of cancer treatment

Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma, according to a study led by researchers at the UCLA Jonsson Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.

28 Apr 2021

Simple exercise can limit harmful weight gain

New research shows that physical activity equivalent to 100 PAI a week can counteract excessive weight gain.

28 Apr 2021

Cloth face masks can be as effective as surgical masks in reducing transmission of COVID-19

Researchers from the Universities of Bristol and Surrey have found that well-fitting, three-layered cloth masks can be as effective at reducing the transmission of COVID-19 as surgical masks.

28 Apr 2021

Early MR imaging can greatly increase the diagnosis of broken-heart syndrome

In almost ten per cent of myocardial infarctions, no obvious cause in the coronary artery can be found. Some of the patients are diagnosed with broken-heart syndrome, while others are left without a diagnosis.

28 Apr 2021

New research sheds light on what causes sudden unexpected death in epilepsy

New research from the University of Virginia School of Medicine has shed light on the No. 1 cause of epilepsy deaths, suggesting a long-sought answer for why some patients die unexpectedly following an epileptic seizure.

28 Apr 2021

Study examines mRNA COVID-19 vaccine’s effectiveness across age and gender

The findings reveal that although the two-dose vaccine regimen initially induces robust antibody response in all age groups, older male individuals are particularly associated with a gradual decline in vaccine-induced immunity six weeks after the second vaccine dose.

28 Apr 2021

Study observes increase in Lyme disease-causing ticks across California’s woodlands and beaches

US-based researchers – at Colorado State University and the Northern Arizona University – have discovered that disease-causing ticks are finding their way onto beachfront properties, including infestations in woodlands and beaches around North California.

28 Apr 2021

Can control theory explain differences in virulence and transmission of SARS-CoV-2?

A new study discusses variations in viral pathogenicity and in transmission, which are responsible for asymptomatic infection and for superspreading events. The ability to understand this would open the way to understand how this virus behaves the way it does, in terms of its virulence, its spread, and its emergent variants of concern.

28 Apr 2021

COVID-19 donor antibodies show broad cross-reactivity against SARS-CoV-2 variants and related viruses

A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.

28 Apr 2021

Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing

Albumedix Ltd. ('Albumedix'), an emerging leader in the enablement of advanced therapies and recognized global leader in recombinant human albumin (rHA) has today announced an extension to its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Charles River Laboratories International, Inc. company.

From Albumedix Ltd. 28 Apr 2021

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

A new study describes a synthetic peptide used as a platform to generate protective adaptive cellular immunity to the virus in rhesus macaques, which are the gold standard for preclinical testing in humans.

28 Apr 2021

Medical Research News

Recovered COVID-19 patients show signs of long-term immunity

Higher ratio of green spaces associated with reduced disparity in coronavirus infection rates

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

Brazilian coronavirus variant could pose a bigger threat than previously assumed

Purified exosomal product accelerates wound healing in preclinical models

Young people of color with a higher income more likely to participate in cancer clinical trials

Mutation in a cancer-causing gene could exacerbate cerebral cavernous malformations in the brain

Involuntary job changes are frequent among breast cancer patients

Study explores link between text anxiety and poor sleep

Topical therapy can help safely reduce side effect of cancer treatment

Simple exercise can limit harmful weight gain

Cloth face masks can be as effective as surgical masks in reducing transmission of COVID-19

Early MR imaging can greatly increase the diagnosis of broken-heart syndrome

New research sheds light on what causes sudden unexpected death in epilepsy

Study examines mRNA COVID-19 vaccine’s effectiveness across age and gender

Study observes increase in Lyme disease-causing ticks across California’s woodlands and beaches

Can control theory explain differences in virulence and transmission of SARS-CoV-2?

COVID-19 donor antibodies show broad cross-reactivity against SARS-CoV-2 variants and related viruses

Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News